Driehaus Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Driehaus Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-147,165	Closed	-$15.8M	–	700
2016 Q4	$15.8M	Buy	147,165 +24,032	+20%	+$2.81M	0.56%	31
2016 Q3	$15.3M	Buy	123,133 +32,432	+36%	+$3.83M	0.52%	40
2016 Q2	$9.64M	Buy	90,701 +47,127	+108%	+$5.47M	0.34%	61
2016 Q1	$4.99M	Buy	+43,574	New	+$5.11M	0.16%	132

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Driehaus Capital Management's CBPO Position: Q1 2017 in Review

Driehaus Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 147,165 shares — an estimated $15.8M sold.

Driehaus Capital Management first reported a position in CBPO in Q1 2016 and held it in 4 quarters. The position peaked at $15.8M in Q4 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Driehaus Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Driehaus Capital Management sold 147,165 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $15.8M.
Driehaus Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 4 quarters.
Driehaus Capital Management's China Biologic Products Holdings, Inc. position peaked at $15.8M in Q4 2016.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Driehaus Capital Management's 13F filing for Q1 2017, filed 16 May 2017.